Oxaliplatin intra-arteriel clinical trials

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

This study is looking at a new way to treat bowel cancer that has spread only to the liver. It combines standard chemotherapy with newer targeted drugs, and a special way of delivering chemotherapy directly to the liver, to see if it works better.